Journal
MICROBIAL PATHOGENESIS
Volume 141, Issue -, Pages -Publisher
ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
DOI: 10.1016/j.micpath.2020.104011
Keywords
antibacterial activity; Bee venom; Antimicrobial peptides; Methicillin-resistant Staphylococcus aureus; MRSA; Enterotoxin-producing S. aureus
Categories
Funding
- Sao Paulo Research Foundation (FAPESP) [2015/14278-6]
- Brazilian National Council for Scientific and Technological Development (CNPq) [162208/2015-4]
- Electronic Microscopy Center, Institute of Biosciences of Botucatu (IBB), Sao Paulo State University (UNESP), Botucatu, Brazil
Ask authors/readers for more resources
The antibacterial activities of apitoxin, a venom produced by Apis mellifera bee, and melittin, an antimicrobial peptide from apitoxin, were tested against planktonic and biofilm states of Staphylococcus aureus methicillin-resistant (MRSA), including clinical, and enterotoxin-producing isolates. Also, the synergism of apitoxin and melittin in combination with oxacillin were evaluated as well. The induced morphological changes on S. aureus cells of both products were detected by transmission electronic microscopy (TEM). The minimum inhibitory concentration (MIC) values were 7.2 mu g/mL, and 6.7 mu g/mL, for apitoxin and melittin, respectively. The minimum bactericidal concentration (MBC) values were 28.7 mu g/mL, and 26 mu g/mL for apitoxin and melittin, respectively. The time-kill curve assays of apitoxin or melittin with oxacillin exhibited bactericidal synergism against MRSA isolates. TEM images showed cell distortion, cell disintegration with leakage of cytoplasmic content and loss of cytoplasm content. However, apitoxin and melittin did not interfere with staphylococcal enterotoxin production or release. Thus, apitoxin and melittin are potential agents against MRSA that can serve as possible models for new antibacterial drugs.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available